{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:32:36Z","timestamp":1790775156927,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.amjmed.2025.04.027","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T22:50:21Z","timestamp":1746053421000},"page":"1238-1247.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-Analysis"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-1105","authenticated-orcid":false,"given":"Do Han","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghyun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pojsakorn","family":"Danpanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn Jun Kit","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith Xin Ning","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N Apoorva","family":"Sasikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan Kai Jun","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karn","family":"Wijarnpreecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0001","article-title":"What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside","volume":"13","author":"Danpanichkul","year":"2024","journal-title":"J Clin Med Res"},{"issue":"12","key":"10.1016\/j.amjmed.2025.04.027_bib0002","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.cgh.2015.07.029","article-title":"Nonalcoholic fatty liver disease review: Diagnosis, treatment, and outcomes","volume":"13","author":"Ahmed","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.amjmed.2025.04.027_bib0003","first-page":"697","article-title":"Examining the nomenclature change from NAFLD and NASH to MASLD and MASH","volume":"19","author":"Rinella","year":"2023","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0004","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Hepatology. Published online"},{"issue":"2","key":"10.1016\/j.amjmed.2025.04.027_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/apt.17846","article-title":"Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Loomba","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.amjmed.2025.04.027_bib0006","first-page":"533","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0007","article-title":"Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake","volume":"22","author":"Aboona","year":"2024","journal-title":"J Gastroenterol Hepatol. Published online August"},{"issue":"6","key":"10.1016\/j.amjmed.2025.04.027_bib0008","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.amjmed.2025.04.027_bib0009","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","article-title":"Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018","volume":"23","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.amjmed.2025.04.027_bib0011","doi-asserted-by":"crossref","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence","volume":"3","author":"Munn","year":"2014","journal-title":"Int J Health Policy Manag"},{"issue":"8","key":"10.1016\/j.amjmed.2025.04.027_bib0012","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/liv.15939","article-title":"Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence","volume":"44","author":"Ciardullo","year":"2024","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.amjmed.2025.04.027_bib0013","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2012.03.024","article-title":"Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Dunn","year":"2012","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.amjmed.2025.04.027_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.47548","article-title":"Alcohol Intake Thresholds Among Individuals With Steatotic Liver Disease","volume":"6","author":"Yeo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155800","article-title":"Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up","volume":"153","author":"Choe","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.amjmed.2025.04.027_bib0017","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cgh.2022.04.014","article-title":"Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"21","author":"Ng","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0018","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12933-022-01725-z","article-title":"The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0019","volume":"10","author":"Zhong","year":"2022"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0020","doi-asserted-by":"crossref","unstructured":"GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022;400(10347):185-235.","DOI":"10.1016\/S0140-6736(22)00847-9"},{"issue":"6","key":"10.1016\/j.amjmed.2025.04.027_bib0021","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jsps.2023.04.002","article-title":"Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines","volume":"31","author":"Matyori","year":"2023","journal-title":"Saudi Pharm J"},{"issue":"16","key":"10.1016\/j.amjmed.2025.04.027_bib0022","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement","volume":"327","author":"Davidson","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.amjmed.2025.04.027_bib0023","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"10.1016\/j.amjmed.2025.04.027_bib0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0026","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13098-022-00811-2","article-title":"Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease","volume":"14","author":"Han","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"10.1016\/j.amjmed.2025.04.027_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070664","article-title":"Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease","volume":"12","author":"Han","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155666","article-title":"Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: results from a large multi-center study","volume":"147","author":"Kouvari","year":"2023","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3748\/wjg.v19.i1.57","article-title":"Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification","volume":"19","author":"Zelber-Sagi","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12876-024-03535-x","article-title":"Determining the sensitivity and specificity of the calculated fatty liver index in comparison with ultrasound","volume":"24","author":"Saberian","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjmed.2025.04.027_bib0031","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.amjmed.2025.04.027_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.01.006","article-title":"Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis","volume":"22","author":"Nasr","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.06.026","article-title":"Global prevalence, clinical characteristics, surveillance, treatment allocation, and outcomes of alcohol-associated hepatocellular carcinoma","author":"Zeng","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.04.027_bib0034","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cld.2017.08.006","article-title":"The use of liver biopsy in nonalcoholic fatty liver disease","volume":"22","author":"Gunn","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.amjmed.2025.04.027_bib0035","unstructured":"Global alcohol action plan. Accessed September 26, 2024. https:\/\/www.who.int\/teams\/mental-health-and-substance-use\/alcohol-drugs-and-addictive-behaviours\/alcohol\/our-activities\/towards-and-action-plan-on-alcohol"},{"issue":"5","key":"10.1016\/j.amjmed.2025.04.027_bib0036","article-title":"Public health policies and alcohol-related liver disease","volume":"1","author":"Ventura-Cots","year":"2019","journal-title":"JHEP Rep"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934325002499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934325002499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T03:40:54Z","timestamp":1756352454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934325002499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0002934325002499"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.04.027","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}